Marshall Wace, LLP Simulations Plus, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 133,278 shares of SLP stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,278
Previous 24,871
435.88%
Holding current value
$2.29 Million
Previous $609,000
281.77%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SLP
# of Institutions
165Shares Held
16.6MCall Options Held
0Put Options Held
35.8K-
Black Rock Inc. New York, NY2.46MShares$42.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$20.2 Million0.0% of portfolio
-
Tributary Capital Management, LLC1.14MShares$19.5 Million0.82% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN875KShares$15 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X0813KShares$14 Million0.01% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $348M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...